Tue, April 18, 2023
Mon, April 17, 2023
Sun, April 16, 2023
Fri, April 14, 2023
Thu, April 13, 2023
Wed, April 12, 2023

Madhu Kumar Maintained (APLS) at Strong Buy with Increased Target to $141 on, Apr 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-141-on-apr-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Madhu Kumar of Goldman Sachs, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $124 to $141 on, Apr 14th, 2023.

Madhu has made no other calls on APLS in the last 4 months.



There are 7 other peers that have a rating on APLS. Out of the 7 peers that are also analyzing APLS, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $58 on, Tuesday, January 3rd, 2023


These are the ratings of the 6 analyists that currently disagree with Madhu


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $87 on, Thursday, February 23rd, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy and Held Target at $80 on, Wednesday, February 22nd, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $139 on, Wednesday, February 22nd, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Tuesday, February 21st, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $75 on, Tuesday, February 21st, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Increased Target to $105 on, Tuesday, February 21st, 2023

Publication Contributing Sources